Neuropsychiatric symptoms among older adults living in two countries in Central Africa (EPIDEMCA study).


Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
01 2019
Historique:
received: 05 04 2018
accepted: 08 09 2018
pubmed: 27 9 2018
medline: 7 8 2019
entrez: 27 9 2018
Statut: ppublish

Résumé

Our study aimed at estimating the prevalence of neuropsychiatric symptoms and investigating associated factors among older adults living in two countries in Central Africa (Central African Republic [CAR] and Republic of Congo [ROC]). The EPIDEMCA multicentre population-based study was carried out in rural and urban areas of CAR and ROC between 2011 and 2012 among people aged 65 and over. After cognitive screening using the Community Screening Interview for Dementia, participants with low performances underwent neurological examination including the brief version of the Neuropsychiatric Inventory Questionnaire (NPI-Q). Multivariate logistic regression analyses were performed to identify factors independently associated with neuropsychiatric symptoms in this population. NPI-Q data were available for 532 participants. Overall, 333 elderly people (63.7%) reported at least one neuropsychiatric symptom. The prevalence of neuropsychiatric symptoms was 89.9% (95% CI, 84.6-95.1) in participants with dementia, 73.4% (95% CI, 65.1-81.7) in participants with mild cognitive impairment (MCI), and 48.7% (95% CI, 42.9-54.6) in participants with no MCI nor dementia after neurological examination (P < 0.0001). The most common symptoms were depression, anxiety, and irritability. Participants living in Gamboma, with normal hearing and with friends in the community, were less likely to present neuropsychiatric symptoms. Physical disability, difficulties in eating, female sex, and dementia were significantly associated with neuropsychiatric symptoms. Neuropsychiatric symptoms are common among older people with neurocognitive disorders in CAR and ROC. Our results confirm those from previous studies in Nigeria and Tanzania. Nevertheless, knowledge of these symptoms remains limited in sub-Saharan Africa, hampering their appropriate management.

Identifiants

pubmed: 30255569
doi: 10.1002/gps.5006
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

169-178

Informations de copyright

© 2018 John Wiley & Sons, Ltd.

Auteurs

Inès Yoro-Zohoun (I)

INSERM UMR1094, Tropical Neuroepidemiology, University of Limoges, Limoges, France.
Institute of Neuroepidemiology and Tropical Neurology, School of Medicine, University of Limoges, Limoges, France.
Laboratory of Chronic Diseases Epidemiology (LEMACEN), Faculty of Health Sciences, School of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.

Philippe Nubukpo (P)

INSERM UMR1094, Tropical Neuroepidemiology, University of Limoges, Limoges, France.
Institute of Neuroepidemiology and Tropical Neurology, School of Medicine, University of Limoges, Limoges, France.
CHU Esquirol, Addictology Department, Limoges, France.

Dismand Houinato (D)

INSERM UMR1094, Tropical Neuroepidemiology, University of Limoges, Limoges, France.
Institute of Neuroepidemiology and Tropical Neurology, School of Medicine, University of Limoges, Limoges, France.
Laboratory of Chronic Diseases Epidemiology (LEMACEN), Faculty of Health Sciences, School of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.

Pascal Mbelesso (P)

INSERM UMR1094, Tropical Neuroepidemiology, University of Limoges, Limoges, France.
Institute of Neuroepidemiology and Tropical Neurology, School of Medicine, University of Limoges, Limoges, France.
Department of Neurology, Amitié Hospital, Bangui, Central African Republic.

Bébène Ndamba-Bandzouzi (B)

Department of Neurology, Brazzaville University Hospital, Brazzaville, Republic of Congo.

Jean-Pierre Clément (JP)

INSERM UMR1094, Tropical Neuroepidemiology, University of Limoges, Limoges, France.
Institute of Neuroepidemiology and Tropical Neurology, School of Medicine, University of Limoges, Limoges, France.
CHU Esquirol Hospital and University Federation of Adult and Geriatric Psychiatry, Limoges, France.

Jean-Francois Dartigues (JF)

Inserm U1219, Bordeaux Population Health Research Centre, Bordeaux, France.

Pierre-Marie Preux (PM)

INSERM UMR1094, Tropical Neuroepidemiology, University of Limoges, Limoges, France.
Institute of Neuroepidemiology and Tropical Neurology, School of Medicine, University of Limoges, Limoges, France.
Department of Medical Information and Evaluation, Clinical Research and Biostatistic Unit, Limoges University Hospital, Limoges, France.

Maëlenn Guerchet (M)

INSERM UMR1094, Tropical Neuroepidemiology, University of Limoges, Limoges, France.
Institute of Neuroepidemiology and Tropical Neurology, School of Medicine, University of Limoges, Limoges, France.
King's College London, Centre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neurosciences, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH